血清分子标志物与结直肠癌肝转移的相关性研究
Study on Correlation between Serum Molecular Markers and Liver Metastasis of Colorectal Cancer
摘要: 结直肠癌被认为是最具危险的消化道癌症，其中的发病率和比例正以惊人的速度增长，对国民身体健康构成了极大威胁。研究表明，结直肠癌的预后取决于其所属的癌症类型，而晚期结直肠癌的五年生存率甚至不足15%。结直肠癌的肝部转移(Colorectal cancer liver metastasis, CRCLM)被认为是最严重的危险，其中20%~25%的病例出现了同步发展的肝部转移。本文总结了几点对血清标志物中的分子与结直肠癌肝转移之间的作用机制及相关研究。CD10、CD133、C反应蛋白等皆与结直肠癌肝转移密切相关，还有很多分子需要我们日后的研究。
Abstract: Colorectal cancer is considered to be the most dangerous cancer of the digestive tract, the incidence and proportion of which are increasing at an alarming rate, for the health of the nation, it poses a great threat. Studies have shown that the prognosis of colorectal cancer depends on the type of cancer it belongs to, and the five-year survival rate for advanced colorectal cancer is even less than 15%. Colorectal cancer liver metastasis (CRCLM) is considered to be the most serious risk. In 20% to 25% of cases, synchronously developing liver metastases occur. This paper summarizes the mecha-nism of action and related study between molecules in serum markers and liver metastasis of colo-rectal cancer. CD10, CD133, C-reactive protein, etc. are closely related to liver metastasis of colorec-tal cancer, and there are many molecules that need to be studied in the future.
文章引用：杨楠, 赵秀峰. 血清分子标志物与结直肠癌肝转移的相关性研究[J]. 临床医学进展, 2023, 13(10): 16692-16697. https://doi.org/10.12677/ACM.2023.13102336

参考文献

[1] Wakao, F., Nishimoto, H., Katanoda, K., Tsukuma, H. and Mikami, H. (2013) Cancer Statistics in Japan, 2013. National Cancer Center.
[2] Fujimoto, Y., Nakanishi, Y., Sekine, S., Yoshimura, K., Akasu, T., et al. (2005) CD10 Expression in Colorectal Carcinoma Correlates with Liver Metastasis. Diseases of the Colon & Rectum, 48, 1883-1889. [Google Scholar] [CrossRef] [PubMed]
[3] Fong, Y., Kemeny, N., Paty, P., Blumgart, L.H. and Cohen, A.M. (1996) Treatment of Colorectal Cancer: Hepatic Metastasis. Seminars in Surgical Oncology, 12, 219-252. [Google Scholar] [CrossRef] 
[4] Shipp, M.A., Vi-jayaraghavan, J., Schmidt, E.V., Masteller, E.L., D’Adamio, L., et al. (1989) Common Acute Lymphoblastic Leukemia Antigen (CALLA) Is Active Neutral Endopeptidase 24.11 (“Enkephalinase”): Direct Evidence by cDNA Transfection Analysis. Proceedings of the National Academy of Sciences of the United States of America, 86, 297-301. [Google Scholar] [CrossRef] [PubMed]
[5] Yao, T., Takata, M., Tustsumi, S., Nishiyama, K., Taguchi, K., et al. (2002) Phenotypic Expression of Gastrointestinal Differentiation Markers in Colorectal Adenocarcinomas with Liver Metastasis. Pathology, 34, 556-560. [Google Scholar] [CrossRef] [PubMed]
[6] Sasaki, T. (2014) Serum CD10 Is Associated with Liver Metastasis in Colorectal Cancer. Journal of Surgical Research, 192, 390-394. [Google Scholar] [CrossRef] [PubMed]
[7] 黄丽娜. CD276、CD133联合CEA、CA199在结直肠癌及其癌前疾病中的表达及意义[D]: [硕士学位论文]. 郑州: 郑州大学, 2018.
[8] 王天赐. 结直肠癌肝转移患者多因素预后分析[D]: [硕士学位论文]. 沈阳: 辽宁中医药大学, 2022.
[9] 傅志成. 血清CRP、白蛋白及GPS评分与大肠癌伴肝转移预后关系[J]. 安徽卫生职业技术学院学报, 2020, 19(3): 100-102.
[10] Maeda, K., Shibutani, M., Otani, H., et al. (2015) Inflammation-Based Factors and Prognosis in Patients with Colorectal Cancer. World Journal of Gastrointestinal Oncology, 7, 111-117. [Google Scholar] [CrossRef] [PubMed]
[11] Køstner, A.H., Kersten, C., Löwenmark, T., Ydsten, K.A., Peltonen, R., Isoniemi, H., et al. (2016) The Prognostic Role of Systemic Inflammation in Patients Undergoing Resection of Colorectal Liver Metastases: C-Reactive Protein (CRP) Is a Strong Negative Prognos-tic Biomarker. Journal of Surgical Oncology, 114, 895-899. [Google Scholar] [CrossRef] [PubMed]
[12] 王兆映, 李传涛, 庞青, 等. 炎症标志物对实体瘤预后价值的研究进展[J]. 齐齐哈尔医学院学报, 2020, 41(1): 84-87.
[13] 张瑜, 李亚, 吴海霞, 等. 血清CRP、白蛋白及GCS预后评分联合检测对结肠癌化疗疗效的预测意义[J]. 中国老年学杂志, 2015, 35(18): 5176-5178.
[14] Gupta, D. and Lis, C.G. (2010) Pretreatment Serum Albumin as a Predictor of Cancer Survival: A Systematic Review of the Epidemiological Literature. Nutrition Journal, 9, Article No. 69. [Google Scholar] [CrossRef] [PubMed]
[15] Virizuela, J.A., et al. (2018) Nutritional Support and Parenteral Nutrition in Cancer Patients: An Expert Consensus Report. Clinical and Translational Oncology, 20, 619-629. [Google Scholar] [CrossRef] [PubMed]
[16] 龚兰, 吴瑜霞, 陈振宇, 等. GPS评分与结直肠癌预后的关系[J]. 检验医学与临床, 2016, 13(14): 1987-1989.
[17] 邱兴帅. 血清FIB、白蛋白、尿素氮联合CEA对结直肠癌的预测价值[D]: [硕士学位论文]. 恩施: 湖北民族大学, 2023.
[18] 李佳, 高佳, 崔婵娟, 等. 血清IV型胶原水平在结直肠癌肝转移中的应用价值[J]. 标记免疫分析与临床, 2021, 28(10): 1689-1692.
[19] 程晋坤, 沈杰, 邓科, 等. 术前AFR水平与同时性结直肠癌肝转移患者临床病理特征关系及预后分析[J]. 现代实用医学, 2021, 33(12): 1581-1584.
[20] 李道亮. 术前CRP、血脂、肿瘤标志物与结直肠癌病理分期及预后的相关性研究[D]: [硕士学位论文]. 海口: 海南医学院, 2022.
[21] 于建文. 纤维蛋白原和D-二聚体术前检测在结直肠癌诊疗中的应用价值[D]: [硕士学位论文]. 南昌: 南昌大学, 2023.
[22] Sis, B., Sarioglu, S., Sokmen, S., et al. (2005) Desmoplasia Measured by Computer Assisted Image Analysis: An Independent Prognostic Marker in Colorectal Carcinoma. Journal of Clinical Pathology, 58, 32-38. [Google Scholar] [CrossRef] [PubMed]
[23] Baluk, P., Morikawa, S., Haskell, A., et al. (2003) Abnormalities of Basement Membrane on Blood Vessels and Endothelial Sprouts in Timors. The American Journal of Pathology, 163, 1801-1805. [Google Scholar] [CrossRef] 
[24] 白傲雪, 张宁苏, 董野, 等. 结直肠癌肝转移的相关因素[J]. 实用中医内科杂志, 2020, 34(5): 120-123.

为你推荐